Transfusion-transmitted arboviruses: Update and systematic review.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
26
01
2022
accepted:
23
09
2022
revised:
18
10
2022
pubmed:
7
10
2022
medline:
21
10
2022
entrez:
6
10
2022
Statut:
epublish
Résumé
The detection of the first cases of transfusion-transmitted West Nile virus in 2002 posed a new challenge for transfusion safety. Institutions like the World Health Organization have stated that blood transfusion centers need to know the epidemiology of the different emerging infectious agents and their impact on blood transfusion. The aim of the study is to review the published cases of arbovirus transmission through transfusion of blood or blood components and to analyze their main clinical and epidemiological characteristics. Systematic literature searches were conducted in MEDLINE, Embase and Scopus. Pairs of review authors selected a variety of scientific publications reporting cases of transfusion-transmitted arboviruses. Main clinical and epidemiological characteristics were reviewed of the cases described. The study protocol was registered in PROSPERO CRD42021270355. A total of 74 cases of transfusion-transmitted infections were identified from 10 arboviruses: West Nile virus (n = 42), dengue virus (n = 18), Zika virus (n = 3), yellow fever vaccine virus (n = 3), tick-borne encephalitis virus (n = 2), Japanese encephalitis virus (n = 2), Powassan virus (n = 1), St. Louis encephalitis virus (n = 1), Ross River virus (n = 1) and Colorado tick fever virus (n = 1). The blood component most commonly involved was red blood cells (N = 35, 47.3%; 95% confidence interval [CI] 35.9% to 58.7%). In 54.1% (N = 40; 95% CI: 42.7%-65.47%) of the cases, the recipient was immunosuppressed. Transmission resulted in death in 18.9% (N = 14; 95% CI: 10.0%-27.8%) of the recipients. In addition, 18 additional arboviruses were identified with a potential threat to transfusion safety. In the last 20 years, the number of published cases of transfusion-transmitted arboviruses increased notably, implicating new arboviruses. In addition, a significant number of arboviruses that may pose a threat to transfusion safety were detected. In the coming years, it is expected that transmission of arboviruses will continue to expand globally. It is therefore essential that all responsible agencies prepare for this potential threat to transfusion safety.
Sections du résumé
BACKGROUND
The detection of the first cases of transfusion-transmitted West Nile virus in 2002 posed a new challenge for transfusion safety. Institutions like the World Health Organization have stated that blood transfusion centers need to know the epidemiology of the different emerging infectious agents and their impact on blood transfusion. The aim of the study is to review the published cases of arbovirus transmission through transfusion of blood or blood components and to analyze their main clinical and epidemiological characteristics.
MATERIAL AND METHODS
Systematic literature searches were conducted in MEDLINE, Embase and Scopus. Pairs of review authors selected a variety of scientific publications reporting cases of transfusion-transmitted arboviruses. Main clinical and epidemiological characteristics were reviewed of the cases described. The study protocol was registered in PROSPERO CRD42021270355.
RESULTS
A total of 74 cases of transfusion-transmitted infections were identified from 10 arboviruses: West Nile virus (n = 42), dengue virus (n = 18), Zika virus (n = 3), yellow fever vaccine virus (n = 3), tick-borne encephalitis virus (n = 2), Japanese encephalitis virus (n = 2), Powassan virus (n = 1), St. Louis encephalitis virus (n = 1), Ross River virus (n = 1) and Colorado tick fever virus (n = 1). The blood component most commonly involved was red blood cells (N = 35, 47.3%; 95% confidence interval [CI] 35.9% to 58.7%). In 54.1% (N = 40; 95% CI: 42.7%-65.47%) of the cases, the recipient was immunosuppressed. Transmission resulted in death in 18.9% (N = 14; 95% CI: 10.0%-27.8%) of the recipients. In addition, 18 additional arboviruses were identified with a potential threat to transfusion safety.
DISCUSSION
In the last 20 years, the number of published cases of transfusion-transmitted arboviruses increased notably, implicating new arboviruses. In addition, a significant number of arboviruses that may pose a threat to transfusion safety were detected. In the coming years, it is expected that transmission of arboviruses will continue to expand globally. It is therefore essential that all responsible agencies prepare for this potential threat to transfusion safety.
Identifiants
pubmed: 36201547
doi: 10.1371/journal.pntd.0010843
pii: PNTD-D-22-00119
pmc: PMC9578600
doi:
Substances chimiques
Yellow Fever Vaccine
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010843Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Hong Kong Med J. 2008 Jun;14(3):170-7
pubmed: 18525084
Clin Infect Dis. 2021 Mar 15;72(6):1051-1054
pubmed: 32539111
Infect Dis (Lond). 2021 Jan;53(1):44-51
pubmed: 32924695
N Engl J Med. 2005 Aug 4;353(5):460-7
pubmed: 16079369
J Infect Dis. 2012 Sep 15;206(6):851-9
pubmed: 22706183
Med J Aust. 2015 Mar 16;202(5):267-70
pubmed: 25758699
Clin Infect Dis. 2019 Jul 18;69(3):450-458
pubmed: 30371754
Transfusion. 2015 May;55(5):965-71
pubmed: 25496479
Emerg Infect Dis. 2006 Oct;12(10):1493-9
pubmed: 17176562
Am J Trop Med Hyg. 1980 Nov;29(6):1359-81
pubmed: 6778230
Nature. 2008 Feb 21;451(7181):990-3
pubmed: 18288193
Transfusion. 2009 Aug;49 Suppl 2:1S-29S
pubmed: 19686562
Emerg Infect Dis. 2013 Nov;19(11):1892-4
pubmed: 24206586
Transpl Infect Dis. 2020 Feb;22(1):e13210
pubmed: 31713971
MMWR Morb Mortal Wkly Rep. 2013 Aug 9;62(31):622-4
pubmed: 23925171
Emerg Infect Dis. 2011 May;17(5):941-3
pubmed: 21529423
Euro Surveill. 2014 Apr 03;19(13):
pubmed: 24721540
J Infect Dis. 2016 Mar 1;213(5):694-702
pubmed: 26908780
N Engl J Med. 2016 Sep 15;375(11):1101-3
pubmed: 27532622
Open Forum Infect Dis. 2019 Jan 03;6(3):ofz001
pubmed: 31660384
J Infect Dis. 2017 Mar 15;215(6):896-901
pubmed: 28453842
Rev Inst Med Trop Sao Paulo. 2001 Nov-Dec;43(6):339-40
pubmed: 11781605
Aust N Z J Public Health. 2013 Oct;37(5):427-33
pubmed: 24090325
Transfus Clin Biol. 2020 Feb;27(1):4-9
pubmed: 31889619
Emerg Infect Dis. 2021 May;27(5):1296-1300
pubmed: 33900178
Transfusion. 2015 May;55(5):961-4
pubmed: 25605570
Emerg Infect Dis. 2001 Sep-Oct;7(5):911-2
pubmed: 11747714
J Trop Pediatr. 2015 Oct;61(5):386-92
pubmed: 26246086
MMWR Morb Mortal Wkly Rep. 2010 Jan 22;59(2):34-7
pubmed: 20094025
Transfusion. 2016 Dec;56(12):3143-3144
pubmed: 27933623
Transfusion. 2010 Oct;50(10):2080-99
pubmed: 20738828
Transpl Infect Dis. 2019 Aug;21(4):e13098
pubmed: 31009160
Transfusion. 2013 Feb;53(2):284-90
pubmed: 22626525
Transfusion. 2017 Dec;57(12):2987-2994
pubmed: 28905395
Emerg Infect Dis. 2018 Jan;24(1):
pubmed: 29043965
Lancet. 1998 Feb 14;351(9101):498
pubmed: 9482448
Transfusion. 2016 Sep;56(9):2278-85
pubmed: 27456861
Transfus Apher Sci. 2017 Apr;56(2):151-153
pubmed: 27825640
Blood. 2011 May 26;117(21):5778-9
pubmed: 21617013
J Hosp Infect. 2020 May;105(1):43-52
pubmed: 31821852
Transfusion. 2017 Mar;57(3pt2):850-856
pubmed: 28164314
J Intern Med. 1989 Mar;225(3):173-7
pubmed: 2703799
Trans R Soc Trop Med Hyg. 2020 Sep 1;114(9):686-689
pubmed: 32333001
Blood. 2019 Apr 25;133(17):1854-1864
pubmed: 30808637
Transfusion. 2020 Sep;60(9):2139-2143
pubmed: 32735379
Emerg Infect Dis. 2019 Feb;25(2):358-360
pubmed: 30511916
Int J Pediatr Adolesc Med. 2020 Sep;7(3):107-111
pubmed: 33094137
Transfusion. 2006 Dec;46(12):2038-46
pubmed: 17176314
Antiviral Res. 2005 Nov;68(2):84-7
pubmed: 16118025
N Engl J Med. 2003 Sep 25;349(13):1236-45
pubmed: 14500806
Rev Inst Med Trop Sao Paulo. 1990 May-Jun;32(3):211-4
pubmed: 2135375
Virol J. 2017 Jun 9;14(1):107
pubmed: 28599678
Mikrobiyol Bul. 2010 Jul;44(3):415-24
pubmed: 21063991
Ecohealth. 2015 Jun;12(2):347-53
pubmed: 25537629
MMWR Morb Mortal Wkly Rep. 2009 Nov 20;58(45):1263-7
pubmed: 19940831
Blood Transfus. 2022 Jul;20(4):267-280
pubmed: 34694219
MMWR Morb Mortal Wkly Rep. 2004 Sep 17;53(36):842-4
pubmed: 15371966
Vector Borne Zoonotic Dis. 2014 Apr;14(4):272-7
pubmed: 24689784
Transfusion. 2020 Feb;60(2):424-429
pubmed: 31633814
Transfusion. 2013 Oct;53(10 Pt 2):2375-83
pubmed: 23926897
Transfusion. 2016 Jan;56(1):215-22
pubmed: 26469514
Clin Exp Vaccine Res. 2014 Jan;3(1):58-77
pubmed: 24427764
MMWR Morb Mortal Wkly Rep. 2007 Feb 2;56(4):76-9
pubmed: 17268405
Vox Sang. 2016 Feb;110(2):196-8
pubmed: 26646317
Emerg Infect Dis. 2016 Jul;22(7):1221-8
pubmed: 27070192
Lancet Child Adolesc Health. 2017 Oct;1(2):134-146
pubmed: 30169203
Transfusion. 2015 Jul;55(7):1655-61
pubmed: 25728040
Transfusion. 2016 Jul;56(7):1684-8
pubmed: 27329551
N Engl J Med. 2008 Oct 2;359(14):1526-7
pubmed: 18832256
Sci Rep. 2018 Apr 12;8(1):6000
pubmed: 29651159
Transfusion. 2013 Apr;53(4):816-26
pubmed: 22804482
Am J Transplant. 2019 Jun;19(6):1838-1846
pubmed: 30672135
J Travel Med. 2005 Apr;12 Suppl 1:S3-11
pubmed: 16225801
Vox Sang. 2010 May;98(4):495-503
pubmed: 19951309
J Clin Virol. 2011 Nov;52(3):278-9
pubmed: 21893428
Eur J Obstet Gynecol Reprod Biol. 2021 Oct;265:162-168
pubmed: 34508989
Transplantation. 2014 May 15;97(9):881-9
pubmed: 24827763
IDCases. 2021 Jul 07;25:e01220
pubmed: 34295644